Sun Pharma establishes Endowed Professorship at Mount Sinai with $2.5 M support to advance derma care

Sun Pharmaceutical Industries has announced the establishment of the Sun Professorship in Dermatology at the Icahn School of Medicine at Mount Sinai, US.

Mark G. Lebwohl, M.D., will be installed as the inaugural professor at Hatch Auditorium at The Mount Sinai Hospital in New York. Supported by a $2.5 million endowment from Sun Pharma, the Sun Professorship will fund academic leadership in dermatology in perpetuity, beginning with Dr Lebwohl as its inaugural incumbent.

Based within the Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai, the professorship will advance research and training, helping translate emerging knowledge into better care and prepare future leaders in the field.

Dr Lebwohl is Chairman Emeritus of the Medical Board of the National Psoriasis Foundation and served as President of the American Academy of Dermatology from 2015 to 2016.